[
  {
    "objectID": "cv/index.html",
    "href": "cv/index.html",
    "title": "Curriculum vitae",
    "section": "",
    "text": "Download current CV\n  \n\n\n  \n\n\nView the tutorial for this template (+ download link)",
    "crumbs": [
      "CV"
    ]
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "About",
    "section": "",
    "text": "Twitter\n  \n  \n    \n     Github\n  \n  \n    \n     LinkedIn\n  \n  \n    \n     Email\n  \n\n\n\n\nAbout\nHi there! I’m Xinyin, and I’m currently a Master of Science student in Pathology at Case Western Reserve University.\nAfter earning my MBBS degree in China, I came to CWRU to pursue my goal of a pathology residency. My coursework, including Statistical Methods (R), is helping me prepare for this next step. I’ve also had some incredible clinical experiences that have deepened my passion for this field.\nI’m excited to share my work and journey with you. Thanks for stopping by!",
    "crumbs": [
      "About"
    ]
  },
  {
    "objectID": "projects/index.html",
    "href": "projects/index.html",
    "title": "Projects",
    "section": "",
    "text": "arXiv Preprint | Code\nDescription"
  },
  {
    "objectID": "projects/index.html#project-a",
    "href": "projects/index.html#project-a",
    "title": "Projects",
    "section": "",
    "text": "arXiv Preprint | Code\nDescription"
  },
  {
    "objectID": "projects/index.html#project-b",
    "href": "projects/index.html#project-b",
    "title": "Projects",
    "section": "Project B",
    "text": "Project B\n\narXiv Preprint | Code\nDescription"
  },
  {
    "objectID": "education/index.html",
    "href": "education/index.html",
    "title": "Experiences",
    "section": "",
    "text": "Aug 2024 - May 2025 (expedcted)\nCase Western Reserve University\nCleveland, OH\nMaster of Science in Pathology (GPA: 4.0 in Year 1)\n\nSept 2019 – Jun 2024\nJinan University\nGuangzhou, China\nBachelor of Medicine & Bachelor of Surgery (MBBS, GPA: 3.55)",
    "crumbs": [
      "Experiences"
    ]
  },
  {
    "objectID": "education/index.html#education",
    "href": "education/index.html#education",
    "title": "Experiences",
    "section": "",
    "text": "Aug 2024 - May 2025 (expedcted)\nCase Western Reserve University\nCleveland, OH\nMaster of Science in Pathology (GPA: 4.0 in Year 1)\n\nSept 2019 – Jun 2024\nJinan University\nGuangzhou, China\nBachelor of Medicine & Bachelor of Surgery (MBBS, GPA: 3.55)",
    "crumbs": [
      "Experiences"
    ]
  },
  {
    "objectID": "blog/index.html",
    "href": "blog/index.html",
    "title": "Blog",
    "section": "",
    "text": "This dashboard uses public data from the NHANES (2017–2020) to establish a pre-pandemic cardiometabolic health baseline for the US adult population. The focus is on key indicators: blood pressure (BP), blood glucose, and cholesterol levels (LDL), evaluating their prevalence and inter-relationships.\n\n\n\n\n\nI selected data for individuals aged 21 to 80 and calculated the mean of three repeated measurements for both Systolic (SBP) and Diastolic (DBP) pressure, a standard practice to obtain clinically stable BP values from the NHANES data. I integrated the key variables—demographics, BP, LDL, and Fasting Glucose, and then removed any missing values.\n\n\n\nTo enable clinically relevant epidemiological analysis, mean blood pressure and LDL level were converted into risk categories based on medical guidelines:\nBP Risk Staging: Categorized average BP into Normal, Elevated, Stage 1 Hypertension, and Stage 2 Hypertension.\nLDL Risk Staging: Categorized LDL levels into Optimal, Borderline, High Risk, and Very High Risk.\n\n\n\n\nThe analysis was structured into Descriptive Statistics and Correlational Analyses to test specific hypotheses:\n\n\nThe purpose is to establish the baseline prevalence of high-risk states in the study population and provide insights for subsequent hypotheses and analyses.\n\n\n\nA. The proportion of individuals in higher-risk LDL categories increases with age.\nB. There is an association between BP and gender.\nC. A positive correlation exists between LDL Cholesterol Level and Mean SBP.\nD. A positive correlation exists between Mean SBP and Fasting Glucose.\n\n\n\nThe purpose is to explore the strength and direction of associations between different health metrics and demographic factors.\n\n\n\n\n\n\nHigh Prevalence: High-risk conditions are common, with Hypertension at 41.9% and High Cholesterol at 25.8%.\nRisk Distribution: Stage 2 Hypertension affects 20.7% of the cohort, while over a quarter of individuals fall into the High Risk or Very High Risk LDL categories.\n\n\n\n\n\n\nThe stacked bar chart presents an unexpected, non-linear relationship between age and LDL risk. While Young Adults (21-39) show the lowest Very High Risk prevalence, the data suggests that Middle-Aged Adults (40-59) are the group with the overall least favorable LDL profile, having the lowest proportion in the Optimal (&lt;100) category. Older Adults (60+) surprisingly have the highest proportion of individuals in the Optimal category. I would interpret this as a result of widespread clinical management initiating after middle age — this age group is most likely to be receiving cholesterol medications, which shifts their LDL distribution back toward the optimal range. This highlights a limitation of using raw cross-sectional data without accounting for treatment effects.\n\n\n\nFemales have a significantly higher prevalence in the Normal BP category compared to males. While the most severe risk (Stage 2 Hypertension) is nearly equal, with a slight edge to males, the male population shows a larger overall representation in the non-optimal risk groups (Elevated, Stage 1, and Stage 2 combined). This indicates that females are generally more likely to maintain optimal blood pressure, while males are more frequently distributed across the various stages of hypertension and pre-hypertension.\n\n\n\nPearson’s r was very low at 0.0682. A minimal association suggests that BP and LDL tend to fluctuate independently in this population.\n\n\n\nPearson’s r was 0.1645, indicating a weak-to-moderate positive correlation. This highlights the synergistic risk between elevated blood sugar and blood pressure, often seen in metabolic syndrome.\n\n\n\n\nThis dashboard provides a data-driven understanding of the pre-pandemic cardiometabolic conditions. The key takeaway is the high baseline prevalence of cardiovascular risk factors and the observed synergistic effect between blood pressure and blood glucose.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "blog/index.html#i.-purpose-and-data-source",
    "href": "blog/index.html#i.-purpose-and-data-source",
    "title": "Blog",
    "section": "",
    "text": "This dashboard uses public data from the NHANES (2017–2020) to establish a pre-pandemic cardiometabolic health baseline for the US adult population. The focus is on key indicators: blood pressure (BP), blood glucose, and cholesterol levels (LDL), evaluating their prevalence and inter-relationships.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "blog/index.html#ii.-data-preparation-and-processing",
    "href": "blog/index.html#ii.-data-preparation-and-processing",
    "title": "Blog",
    "section": "",
    "text": "I selected data for individuals aged 21 to 80 and calculated the mean of three repeated measurements for both Systolic (SBP) and Diastolic (DBP) pressure, a standard practice to obtain clinically stable BP values from the NHANES data. I integrated the key variables—demographics, BP, LDL, and Fasting Glucose, and then removed any missing values.\n\n\n\nTo enable clinically relevant epidemiological analysis, mean blood pressure and LDL level were converted into risk categories based on medical guidelines:\nBP Risk Staging: Categorized average BP into Normal, Elevated, Stage 1 Hypertension, and Stage 2 Hypertension.\nLDL Risk Staging: Categorized LDL levels into Optimal, Borderline, High Risk, and Very High Risk.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "blog/index.html#iii.-hypotheses-and-analyses",
    "href": "blog/index.html#iii.-hypotheses-and-analyses",
    "title": "Blog",
    "section": "",
    "text": "The analysis was structured into Descriptive Statistics and Correlational Analyses to test specific hypotheses:\n\n\nThe purpose is to establish the baseline prevalence of high-risk states in the study population and provide insights for subsequent hypotheses and analyses.\n\n\n\nA. The proportion of individuals in higher-risk LDL categories increases with age.\nB. There is an association between BP and gender.\nC. A positive correlation exists between LDL Cholesterol Level and Mean SBP.\nD. A positive correlation exists between Mean SBP and Fasting Glucose.\n\n\n\nThe purpose is to explore the strength and direction of associations between different health metrics and demographic factors.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "blog/index.html#iv.-key-findings-and-conclusions",
    "href": "blog/index.html#iv.-key-findings-and-conclusions",
    "title": "Blog",
    "section": "",
    "text": "High Prevalence: High-risk conditions are common, with Hypertension at 41.9% and High Cholesterol at 25.8%.\nRisk Distribution: Stage 2 Hypertension affects 20.7% of the cohort, while over a quarter of individuals fall into the High Risk or Very High Risk LDL categories.\n\n\n\n\n\n\nThe stacked bar chart presents an unexpected, non-linear relationship between age and LDL risk. While Young Adults (21-39) show the lowest Very High Risk prevalence, the data suggests that Middle-Aged Adults (40-59) are the group with the overall least favorable LDL profile, having the lowest proportion in the Optimal (&lt;100) category. Older Adults (60+) surprisingly have the highest proportion of individuals in the Optimal category. I would interpret this as a result of widespread clinical management initiating after middle age — this age group is most likely to be receiving cholesterol medications, which shifts their LDL distribution back toward the optimal range. This highlights a limitation of using raw cross-sectional data without accounting for treatment effects.\n\n\n\nFemales have a significantly higher prevalence in the Normal BP category compared to males. While the most severe risk (Stage 2 Hypertension) is nearly equal, with a slight edge to males, the male population shows a larger overall representation in the non-optimal risk groups (Elevated, Stage 1, and Stage 2 combined). This indicates that females are generally more likely to maintain optimal blood pressure, while males are more frequently distributed across the various stages of hypertension and pre-hypertension.\n\n\n\nPearson’s r was very low at 0.0682. A minimal association suggests that BP and LDL tend to fluctuate independently in this population.\n\n\n\nPearson’s r was 0.1645, indicating a weak-to-moderate positive correlation. This highlights the synergistic risk between elevated blood sugar and blood pressure, often seen in metabolic syndrome.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "blog/index.html#v.-conclusion",
    "href": "blog/index.html#v.-conclusion",
    "title": "Blog",
    "section": "",
    "text": "This dashboard provides a data-driven understanding of the pre-pandemic cardiometabolic conditions. The key takeaway is the high baseline prevalence of cardiovascular risk factors and the observed synergistic effect between blood pressure and blood glucose.",
    "crumbs": [
      "Blog"
    ]
  },
  {
    "objectID": "dashboard/data.html",
    "href": "dashboard/data.html",
    "title": "data",
    "section": "",
    "text": "library(nhanesA)\nlibrary(tidyverse)\n\n── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──\n✔ dplyr     1.1.4     ✔ readr     2.1.5\n✔ forcats   1.0.0     ✔ stringr   1.5.1\n✔ ggplot2   3.5.2     ✔ tibble    3.3.0\n✔ lubridate 1.9.4     ✔ tidyr     1.3.1\n✔ purrr     1.1.0     \n── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──\n✖ dplyr::filter() masks stats::filter()\n✖ dplyr::lag()    masks stats::lag()\nℹ Use the conflicted package (&lt;http://conflicted.r-lib.org/&gt;) to force all conflicts to become errors\n\n\n\ndemo_raw &lt;- nhanes('P_DEMO') |&gt; tibble()\nprint(head(demo_raw))\n\n# A tibble: 6 × 29\n    SEQN SDDSRVYR RIDSTATR RIAGENDR RIDAGEYR RIDAGEMN RIDRETH1 RIDRETH3 RIDEXMON\n   &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;       &lt;dbl&gt;    &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;   \n1 109263 NHANES … Both in… Male            2       NA Other R… Non-His… May 1 t…\n2 109264 NHANES … Both in… Female         13       NA Mexican… Mexican… May 1 t…\n3 109265 NHANES … Both in… Male            2       NA Non-His… Non-His… May 1 t…\n4 109266 NHANES … Both in… Female         29       NA Other R… Non-His… May 1 t…\n5 109267 NHANES … Intervi… Female         21       NA Other H… Other H… &lt;NA&gt;    \n6 109268 NHANES … Intervi… Female         18       NA Non-His… Non-His… &lt;NA&gt;    \n# ℹ 20 more variables: DMDBORN4 &lt;fct&gt;, DMDYRUSZ &lt;fct&gt;, DMDEDUC2 &lt;fct&gt;,\n#   DMDMARTZ &lt;fct&gt;, RIDEXPRG &lt;fct&gt;, SIALANG &lt;fct&gt;, SIAPROXY &lt;fct&gt;,\n#   SIAINTRP &lt;fct&gt;, FIALANG &lt;fct&gt;, FIAPROXY &lt;fct&gt;, FIAINTRP &lt;fct&gt;,\n#   MIALANG &lt;fct&gt;, MIAPROXY &lt;fct&gt;, MIAINTRP &lt;fct&gt;, AIALANGA &lt;fct&gt;,\n#   WTINTPRP &lt;dbl&gt;, WTMECPRP &lt;dbl&gt;, SDMVPSU &lt;dbl&gt;, SDMVSTRA &lt;dbl&gt;,\n#   INDFMPIR &lt;dbl&gt;\n\nsaveRDS(demo_raw, \"data/P_DEMO.Rds\")\ndemo_raw &lt;- readRDS(\"data/P_DEMO.Rds\")\n\n\nbp_raw &lt;- nhanes('P_BPXO') |&gt; tibble()\nprint(head(bp_raw))\n\n# A tibble: 6 × 12\n    SEQN BPAOARM BPAOCSZ         BPXOSY1 BPXODI1 BPXOSY2 BPXODI2 BPXOSY3 BPXODI3\n   &lt;dbl&gt; &lt;fct&gt;   &lt;fct&gt;             &lt;dbl&gt;   &lt;dbl&gt;   &lt;dbl&gt;   &lt;dbl&gt;   &lt;dbl&gt;   &lt;dbl&gt;\n1 109264 \"Right\" 22-31.9 (bladd…     109      67     109      68     106      66\n2 109266 \"Right\" 32-41.9 (bladd…      99      56      99      55      99      52\n3 109270 \"Right\" 22-31.9 (bladd…     123      73     124      77     127      70\n4 109271 \"Right\" 32-41.9 (bladd…     102      65     108      68     111      68\n5 109273 \"Right\" 22-31.9 (bladd…     116      68     110      66     115      68\n6 109274 \"\"      22-31.9 (bladd…     138      70     132      69     132      71\n# ℹ 3 more variables: BPXOPLS1 &lt;dbl&gt;, BPXOPLS2 &lt;dbl&gt;, BPXOPLS3 &lt;dbl&gt;\n\nsaveRDS(bp_raw, \"data/P_BPXO.Rds\")\nbp_raw &lt;- readRDS(\"data/P_BPXO.Rds\")\n\n\nchol_raw &lt;- nhanes('P_TRIGLY') |&gt; tibble()\nprint(head(chol_raw))\n\n# A tibble: 6 × 10\n    SEQN WTSAFPRP LBXTR LBDTRSI LBDLDL LBDLDLSI LBDLDLM LBDLDMSI LBDLDLN\n   &lt;dbl&gt;    &lt;dbl&gt; &lt;dbl&gt;   &lt;dbl&gt;  &lt;dbl&gt;    &lt;dbl&gt;   &lt;dbl&gt;    &lt;dbl&gt;   &lt;dbl&gt;\n1 109264   27533.    40   0.452     86     2.22      82     2.12      85\n2 109271   18101.    84   0.948     97     2.51      96     2.48      98\n3 109274   16282.   133   1.50      49     1.27      54     1.40      52\n4 109277   32230.    24   0.271     64     1.66      62     1.60      61\n5 109282   79007.   132   1.49     164     4.24     163     4.22     166\n6 109286       0    192   2.17     131     3.39     136     3.52     135\n# ℹ 1 more variable: LBDLDNSI &lt;dbl&gt;\n\nsaveRDS(chol_raw, \"data/P_TRIGLY.Rds\")\nchol_raw &lt;- readRDS(\"data/P_TRIGLY.Rds\")\n\n\npa_raw &lt;- nhanes('P_PAQ') |&gt; tibble()\nprint(head(pa_raw))\n\n# A tibble: 6 × 17\n    SEQN PAQ605 PAQ610 PAD615 PAQ620 PAQ625 PAD630 PAQ635 PAQ640 PAD645 PAQ650\n   &lt;dbl&gt; &lt;fct&gt;   &lt;dbl&gt;  &lt;dbl&gt; &lt;fct&gt;   &lt;dbl&gt;  &lt;dbl&gt; &lt;fct&gt;   &lt;dbl&gt;  &lt;dbl&gt; &lt;fct&gt; \n1 109266 No         NA     NA No         NA     NA No         NA     NA Yes   \n2 109267 No         NA     NA No         NA     NA No         NA     NA Yes   \n3 109268 Yes         5    540 Yes         5    300 No         NA     NA No    \n4 109271 No         NA     NA Yes         2    120 No         NA     NA No    \n5 109273 Yes         3    240 No         NA     NA No         NA     NA No    \n6 109274 Yes         7    480 Yes         6    360 Yes         7     60 No    \n# ℹ 6 more variables: PAQ655 &lt;dbl&gt;, PAD660 &lt;dbl&gt;, PAQ665 &lt;fct&gt;, PAQ670 &lt;dbl&gt;,\n#   PAD675 &lt;dbl&gt;, PAD680 &lt;dbl&gt;\n\nsaveRDS(pa_raw, \"data/P_PAQ.Rds\")\npa_raw &lt;- readRDS(\"data/P_PAQ.Rds\")\n\n\nbs_raw &lt;- nhanes('P_GLU') |&gt; tibble()\nprint(head(bs_raw))\n\n# A tibble: 6 × 4\n    SEQN WTSAFPRP LBXGLU LBDGLUSI\n   &lt;dbl&gt;    &lt;dbl&gt;  &lt;dbl&gt;    &lt;dbl&gt;\n1 109264   27533.     97     5.38\n2 109271   18101.    103     5.72\n3 109274   16282.    154     8.55\n4 109277   32230.     92     5.11\n5 109282   79007.     95     5.27\n6 109286       0      92     5.11\n\nsaveRDS(bs_raw, \"data/P_GLU.Rds\")\nbs_raw &lt;- readRDS(\"data/P_GLU.Rds\")\n\n\nNEW_merged_data &lt;- demo_raw %&gt;%\n  left_join(bp_raw, by = \"SEQN\") %&gt;%\n  left_join(pa_raw, by = \"SEQN\") %&gt;%\n  left_join(chol_raw, by = \"SEQN\") %&gt;%\n  left_join(bs_raw, by = \"SEQN\")\n\nsaveRDS(NEW_merged_data, \"data/NEW_merged_data.Rds\")\n\nprint(head(NEW_merged_data))\n\n# A tibble: 6 × 68\n    SEQN SDDSRVYR RIDSTATR RIAGENDR RIDAGEYR RIDAGEMN RIDRETH1 RIDRETH3 RIDEXMON\n   &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;       &lt;dbl&gt;    &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;   \n1 109263 NHANES … Both in… Male            2       NA Other R… Non-His… May 1 t…\n2 109264 NHANES … Both in… Female         13       NA Mexican… Mexican… May 1 t…\n3 109265 NHANES … Both in… Male            2       NA Non-His… Non-His… May 1 t…\n4 109266 NHANES … Both in… Female         29       NA Other R… Non-His… May 1 t…\n5 109267 NHANES … Intervi… Female         21       NA Other H… Other H… &lt;NA&gt;    \n6 109268 NHANES … Intervi… Female         18       NA Non-His… Non-His… &lt;NA&gt;    \n# ℹ 59 more variables: DMDBORN4 &lt;fct&gt;, DMDYRUSZ &lt;fct&gt;, DMDEDUC2 &lt;fct&gt;,\n#   DMDMARTZ &lt;fct&gt;, RIDEXPRG &lt;fct&gt;, SIALANG &lt;fct&gt;, SIAPROXY &lt;fct&gt;,\n#   SIAINTRP &lt;fct&gt;, FIALANG &lt;fct&gt;, FIAPROXY &lt;fct&gt;, FIAINTRP &lt;fct&gt;,\n#   MIALANG &lt;fct&gt;, MIAPROXY &lt;fct&gt;, MIAINTRP &lt;fct&gt;, AIALANGA &lt;fct&gt;,\n#   WTINTPRP &lt;dbl&gt;, WTMECPRP &lt;dbl&gt;, SDMVPSU &lt;dbl&gt;, SDMVSTRA &lt;dbl&gt;,\n#   INDFMPIR &lt;dbl&gt;, BPAOARM &lt;fct&gt;, BPAOCSZ &lt;fct&gt;, BPXOSY1 &lt;dbl&gt;, BPXODI1 &lt;dbl&gt;,\n#   BPXOSY2 &lt;dbl&gt;, BPXODI2 &lt;dbl&gt;, BPXOSY3 &lt;dbl&gt;, BPXODI3 &lt;dbl&gt;, …\n\nprint(dim(NEW_merged_data))\n\n[1] 15560    68\n\n\n\nclean_data_adults &lt;- NEW_merged_data %&gt;%\n  filter(RIDSTATR == \"Both interviewed and MEC examined\") %&gt;%       \n  filter(RIDAGEYR &lt; 80) %&gt;%       \n  filter(RIDAGEYR &gt;= 21)          \n\ncat(\"case #:\", nrow(clean_data_adults), \"\\n\")\n\ncase #: 7853 \n\nprint(head(clean_data_adults))\n\n# A tibble: 6 × 68\n    SEQN SDDSRVYR RIDSTATR RIAGENDR RIDAGEYR RIDAGEMN RIDRETH1 RIDRETH3 RIDEXMON\n   &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;       &lt;dbl&gt;    &lt;dbl&gt; &lt;fct&gt;    &lt;fct&gt;    &lt;fct&gt;   \n1 109266 NHANES … Both in… Female         29       NA Other R… Non-His… May 1 t…\n2 109271 NHANES … Both in… Male           49       NA Non-His… Non-His… May 1 t…\n3 109273 NHANES … Both in… Male           36       NA Non-His… Non-His… May 1 t…\n4 109274 NHANES … Both in… Male           68       NA Other R… Other R… Novembe…\n5 109282 NHANES … Both in… Male           76       NA Non-His… Non-His… May 1 t…\n6 109284 NHANES … Both in… Female         44       NA Mexican… Mexican… Novembe…\n# ℹ 59 more variables: DMDBORN4 &lt;fct&gt;, DMDYRUSZ &lt;fct&gt;, DMDEDUC2 &lt;fct&gt;,\n#   DMDMARTZ &lt;fct&gt;, RIDEXPRG &lt;fct&gt;, SIALANG &lt;fct&gt;, SIAPROXY &lt;fct&gt;,\n#   SIAINTRP &lt;fct&gt;, FIALANG &lt;fct&gt;, FIAPROXY &lt;fct&gt;, FIAINTRP &lt;fct&gt;,\n#   MIALANG &lt;fct&gt;, MIAPROXY &lt;fct&gt;, MIAINTRP &lt;fct&gt;, AIALANGA &lt;fct&gt;,\n#   WTINTPRP &lt;dbl&gt;, WTMECPRP &lt;dbl&gt;, SDMVPSU &lt;dbl&gt;, SDMVSTRA &lt;dbl&gt;,\n#   INDFMPIR &lt;dbl&gt;, BPAOARM &lt;fct&gt;, BPAOCSZ &lt;fct&gt;, BPXOSY1 &lt;dbl&gt;, BPXODI1 &lt;dbl&gt;,\n#   BPXOSY2 &lt;dbl&gt;, BPXODI2 &lt;dbl&gt;, BPXOSY3 &lt;dbl&gt;, BPXODI3 &lt;dbl&gt;, …\n\nsaveRDS(clean_data_adults, \"data/clean_adult_data.Rds\")\n\n\n# Calculate mean SBP/DBP and BP level\nfinal_data &lt;- clean_data_adults\nfinal_data$Mean_SBP &lt;- base::rowMeans(\n    clean_data_adults[, c(\"BPXOSY1\", \"BPXOSY2\", \"BPXOSY3\")], \n    na.rm = TRUE\n)\nfinal_data$Mean_DBP &lt;- base::rowMeans(\n    clean_data_adults[, c(\"BPXODI1\", \"BPXODI2\", \"BPXODI3\")], \n    na.rm = TRUE\n)\nfinal_data$Mean_SBP &lt;- round(final_data$Mean_SBP, 0)\nfinal_data$Mean_DBP &lt;- round(final_data$Mean_DBP, 0)\n\n     \nfinal_data &lt;- final_data %&gt;%\n  mutate(\n    BP_Category = case_when(\n      (Mean_SBP &gt;= 140) | (Mean_DBP &gt;= 90) ~ \"4. Stage 2 Hypertension (&gt;=140 or &gt;=90)\",\n      (Mean_SBP &gt;= 130 & Mean_SBP &lt; 140) | (Mean_DBP &gt;= 80 & Mean_DBP &lt; 90) ~ \"3. Stage 1 Hypertension (130-139 or 80-89)\",\n      (Mean_SBP &gt;= 120 & Mean_SBP &lt; 130) & (Mean_DBP &lt; 80) ~ \"2. Elevated (120-129 and &lt;80)\",\n      (Mean_SBP &lt; 120) & (Mean_DBP &lt; 80) ~ \"1. Normal (&lt;120 and &lt;80)\",\n      TRUE ~ NA_character_\n    )\n  ) %&gt;%\n  mutate(\n    BP_Category = factor(BP_Category, levels = c(\n      \"1. Normal (&lt;120 and &lt;80)\",\n      \"2. Elevated (120-129 and &lt;80)\",\n      \"3. Stage 1 Hypertension (130-139 or 80-89)\",\n      \"4. Stage 2 Hypertension (&gt;=140 or &gt;=90)\"\n    ))\n  )\n\n\nprint(table(final_data$BP_Category, useNA = \"ifany\"))\n\n\n                  1. Normal (&lt;120 and &lt;80) \n                                      2965 \n             2. Elevated (120-129 and &lt;80) \n                                       995 \n3. Stage 1 Hypertension (130-139 or 80-89) \n                                      1567 \n   4. Stage 2 Hypertension (&gt;=140 or &gt;=90) \n                                      1556 \n                                      &lt;NA&gt; \n                                       770 \n\n#Chol level\nfinal_data &lt;- final_data %&gt;%\n  mutate(\n    LDL_Category = case_when(\n      LBDLDL &gt;= 160 ~ \"4. Very High Risk (&gt;=160)\",\n      LBDLDL &gt;= 130 & LBDLDL &lt; 160 ~ \"3. High Risk (130-159)\",\n      LBDLDL &gt;= 100 & LBDLDL &lt; 130 ~ \"2. Borderline (100-129)\",\n      LBDLDL &lt; 100 ~ \"1. Optimal (&lt;100)\",\n      TRUE ~ NA_character_\n    )\n  ) %&gt;%\n  mutate(\n    LDL_Category = factor(LDL_Category, levels = c(\n      \"1. Optimal (&lt;100)\",\n      \"2. Borderline (100-129)\",\n      \"3. High Risk (130-159)\",\n      \"4. Very High Risk (&gt;=160)\"\n    ))\n  )\n\nprint(table(final_data$LDL_Category, useNA = \"ifany\"))\n\n\n        1. Optimal (&lt;100)   2. Borderline (100-129)    3. High Risk (130-159) \n                     1521                      1156                       627 \n4. Very High Risk (&gt;=160)                      &lt;NA&gt; \n                      297                      4252 \n\nsaveRDS(final_data, \"data/final_data.Rds\")\n\n\nfinal_data &lt;- readRDS(\"data/final_data.Rds\") %&gt;%\n  select(\n    #Demo\n    ID = SEQN,\n    RIDSTATR,\n    Age = RIDAGEYR,\n    Gender = RIAGENDR,\n    #Key variables\n    Mean_SBP, \n    Mean_DBP,\n    BP_Category,\n    LDL_Cholesterol = LBDLDL,\n    LDL_Category,\n    Triglycerides = LBXTR,\n    Fasting_Glucose = LBXGLU\n  )%&gt;%\n\n  drop_na() \n\nfinal_n &lt;- nrow(final_data)\ncat(\"Study 1 case number:\", final_n, \"\\n\")\n\nStudy 1 case number: 3270 \n\nprint(head(final_data))\n\n# A tibble: 6 × 11\n      ID RIDSTATR       Age Gender Mean_SBP Mean_DBP BP_Category LDL_Cholesterol\n   &lt;dbl&gt; &lt;fct&gt;        &lt;dbl&gt; &lt;fct&gt;     &lt;dbl&gt;    &lt;dbl&gt; &lt;fct&gt;                 &lt;dbl&gt;\n1 109271 Both interv…    49 Male        107       67 1. Normal …              97\n2 109274 Both interv…    68 Male        134       70 3. Stage 1…              49\n3 109282 Both interv…    76 Male        139       73 3. Stage 1…             164\n4 109290 Both interv…    68 Female      121       60 2. Elevate…             105\n5 109292 Both interv…    58 Male        138       97 4. Stage 2…             102\n6 109297 Both interv…    30 Female      104       70 1. Normal …             123\n# ℹ 3 more variables: LDL_Category &lt;fct&gt;, Triglycerides &lt;dbl&gt;,\n#   Fasting_Glucose &lt;dbl&gt;\n\nsaveRDS(final_data, \"data/final_variables.rds\")"
  }
]